Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Shree Sharma

Concepts (117)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Renal Cell
2
2010
101
0.660
Why?
Kidney Neoplasms
2
2010
172
0.630
Why?
Glomerulonephritis, Membranous
3
2020
27
0.520
Why?
Diabetic Nephropathies
1
2013
61
0.420
Why?
Kidney
2
2013
672
0.380
Why?
Angiogenesis Inducing Agents
1
2010
8
0.370
Why?
Glomerulonephritis, IGA
1
2010
5
0.370
Why?
PAX2 Transcription Factor
1
2010
22
0.360
Why?
Podocytes
1
2010
19
0.360
Why?
Carcinoma, Papillary
1
2010
49
0.350
Why?
Neovascularization, Physiologic
1
2010
68
0.350
Why?
Proto-Oncogene Proteins B-raf
1
2010
78
0.340
Why?
Diabetes Mellitus
1
2013
279
0.340
Why?
Vascular Endothelial Growth Factor A
1
2010
183
0.320
Why?
Neovascularization, Pathologic
1
2010
153
0.320
Why?
Angiogenesis Inhibitors
1
2010
182
0.310
Why?
Heart Diseases
1
2010
210
0.300
Why?
Immunohistochemistry
1
2010
972
0.290
Why?
Colorectal Neoplasms
1
2010
253
0.280
Why?
Adenocarcinoma
1
2010
401
0.270
Why?
Kidney Diseases
2
2019
211
0.240
Why?
Lupus Nephritis
1
2020
17
0.180
Why?
Lupus Erythematosus, Systemic
1
2020
68
0.170
Why?
Biopsy
2
2013
591
0.170
Why?
Glomerulonephritis
1
2019
14
0.170
Why?
Humans
13
2020
49898
0.140
Why?
Proflavine
1
2015
1
0.130
Why?
Endothelin-1
1
2015
31
0.120
Why?
Fluorescent Dyes
1
2015
105
0.120
Why?
Point-of-Care Systems
1
2015
55
0.120
Why?
Phenazopyridine
1
2014
3
0.120
Why?
Nephritis, Interstitial
1
2014
9
0.110
Why?
Contrast Media
1
2015
186
0.110
Why?
Glomerular Filtration Rate
1
2013
110
0.110
Why?
Myocardium
1
2015
443
0.100
Why?
Vascular Endothelial Growth Factors
1
2010
13
0.090
Why?
Microscopy, Electron, Transmission
1
2010
75
0.090
Why?
Colonic Neoplasms
1
2012
158
0.090
Why?
Proteinuria
1
2010
36
0.090
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2010
11
0.090
Why?
Hematuria
1
2010
26
0.090
Why?
Fluorescent Antibody Technique
1
2010
112
0.090
Why?
Fibroblast Growth Factors
1
2010
45
0.090
Why?
Neoplasms
1
2020
1233
0.090
Why?
Von Hippel-Lindau Tumor Suppressor Protein
1
2010
8
0.090
Why?
Female
5
2019
26560
0.090
Why?
Patents as Topic
1
2010
9
0.090
Why?
Gene Expression Regulation
1
2015
964
0.090
Why?
Integrins
1
2010
30
0.090
Why?
DNA, Neoplasm
1
2010
145
0.090
Why?
DNA Mutational Analysis
1
2010
176
0.090
Why?
Cell Nucleus
1
2010
186
0.090
Why?
Neoplasm Metastasis
1
2010
235
0.090
Why?
Aging
1
2015
669
0.090
Why?
Matrix Metalloproteinases
1
2010
47
0.080
Why?
Amlodipine
1
2009
14
0.080
Why?
Renal Insufficiency
1
2010
107
0.080
Why?
Genetic Therapy
1
2010
117
0.080
Why?
Fluorobenzenes
1
2009
21
0.080
Why?
Cardiomegaly
1
2009
39
0.080
Why?
TOR Serine-Threonine Kinases
1
2010
76
0.080
Why?
Stem Cell Transplantation
1
2010
179
0.080
Why?
Hypercholesterolemia
1
2009
36
0.080
Why?
Immunoglobulin G
2
2020
184
0.080
Why?
Calcium Channel Blockers
1
2009
63
0.080
Why?
Intracellular Signaling Peptides and Proteins
1
2010
139
0.080
Why?
Male
6
2020
25437
0.080
Why?
Sulfonamides
1
2009
125
0.080
Why?
Sensitivity and Specificity
1
2010
858
0.080
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2009
137
0.080
Why?
Pyrimidines
1
2009
192
0.080
Why?
Drug Delivery Systems
1
2010
143
0.080
Why?
Nanoparticles
1
2010
151
0.080
Why?
Predictive Value of Tests
1
2010
907
0.070
Why?
Diagnosis, Differential
1
2010
1036
0.070
Why?
Aged
3
2020
9447
0.070
Why?
Models, Biological
1
2010
719
0.070
Why?
Antibodies, Monoclonal
1
2010
457
0.060
Why?
Retrospective Studies
1
2013
6123
0.050
Why?
Middle Aged
2
2013
12285
0.050
Why?
Neural Cell Adhesion Molecules
1
2020
9
0.050
Why?
Thrombospondins
1
2020
8
0.050
Why?
Receptors, Phospholipase A2
1
2020
14
0.050
Why?
Calcium-Binding Proteins
1
2020
54
0.040
Why?
Autoantigens
1
2020
50
0.040
Why?
Autoantibodies
1
2020
114
0.040
Why?
Kidney Glomerulus
1
2019
39
0.040
Why?
Multiple Myeloma
1
2012
2915
0.040
Why?
Aspartic Acid Endopeptidases
1
2015
16
0.030
Why?
beta-Galactosidase
1
2015
35
0.030
Why?
Gene Knockdown Techniques
1
2015
106
0.030
Why?
Metalloendopeptidases
1
2015
69
0.030
Why?
Microscopy, Fluorescence
1
2015
164
0.030
Why?
Estrogen Receptor alpha
1
2015
86
0.030
Why?
Enzyme Activation
1
2015
272
0.030
Why?
RNA Interference
1
2015
178
0.030
Why?
Fibrosis
1
2015
178
0.030
Why?
Up-Regulation
1
2015
446
0.030
Why?
Fibroblasts
1
2015
352
0.030
Why?
Mice
2
2015
5658
0.020
Why?
Fatal Outcome
1
2012
194
0.020
Why?
Cell Line, Tumor
1
2015
1388
0.020
Why?
Cholesterol, Dietary
1
2009
19
0.020
Why?
Receptors, LDL
1
2009
67
0.020
Why?
Lipids
1
2009
145
0.020
Why?
Drug Therapy, Combination
1
2009
380
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
579
0.020
Why?
Signal Transduction
1
2015
1608
0.020
Why?
Body Weight
1
2009
512
0.020
Why?
Animals
2
2015
13100
0.020
Why?
Hematopoietic Stem Cell Transplantation
1
2012
554
0.020
Why?
Gene Expression
1
2009
612
0.020
Why?
Blood Pressure
1
2009
519
0.020
Why?
Mice, Knockout
1
2009
835
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2012
994
0.020
Why?
Disease Models, Animal
1
2009
1411
0.010
Why?
Treatment Outcome
1
2009
5176
0.010
Why?
Sharma's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description